1Henle G,Henle W.Epstein-Barr virus-specific serum antibody as an outstanding feature of nasopharyngeal carcinoma.Int J cancer,1976,17:1.
2Fones-Jan A,Chan SH,Tsao SY,et al.Enzyme-linked immunosorbent assay (ELISA) for IgA and IgG antibodies to Epstein-Barr virus Ribonucleotide reductase in patients with nasopharyngeal carcinoma.Int J cancer 1994,59:739.
3Gunthel C J, Ng V, McGrath M, et al. Association of Epstein-Barr virus types 1 and 2 with acquired immunodeficiency syndrome-related primary central nervous system lymphomas [J]. Blood, 1994,83(2) :618-619.
4Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control [J]. Expert Rev Anti Infect Ther, 2006, 4 (6) : 1039-1049.
5Crawford DH, Macsween KF, Higgins CD, et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis [J]. Clin Infect Dis,2006,43(3):276-2S2.
6Figueira-Silva CM, Pereira FE. Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitoria,State of Espirito Santo, Brazil [J]. Rev Soc Bras Med Trop, 2004,37 (5) : 409-412.
7Lai PK, Mackay-Scollay EM. Epidemiological studies of Epstein-Barr herpes virus infection in Western Australia [J ]. J Hyg (Lond), 1975,74: 329-337.
8Tsai WS, Chang MH. Seroepidemiological study of Epstein-Barr virus infection in children in Taipei [ J ]. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, 1989,30: 81-86.
9Kangro HO, Osman HK. Seroprevalence of antibodies to human herpes viruses in England and Hong Kong [J]. J Med Virol, 1994,43 : 91-96.
10Du HJ, Zhou L, Liu HT, et al. A serological survey of Epstein-Barr virus infection in children in Beijing [J]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 2008, 22 (1) : 30-32.
